Enko designs safe and sustainable solutions to farmers’ biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs. Founded in 2017 and led by a team of proven scientists, entrepreneurs and agriculture industry veterans, Enko is backed by investors including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund.
| Website | https://www.enko.ag |
| Revenue | $11.6 million |
| Employees | 51 (0 on RocketReach) |
| Industry | Biotechnology |
| Keywords | Sustainable Agriculture, Crop Protection, Biotechnology, Agricultural Innovation, Drug Discovery, Plant Health, Precision Agriculture, Agricultural Technology, Crop Science, Farming Solutions, Agricultural Research, Plant Biotechnology, Sustainable Farming, Agricultural Chemicals, Crop Enhancement, Agrochemicals, Plant Protection, Agricultural Inputs |
| Competitors | Bayer, BASF, Dow, Syngenta, Corteva Agriscience, Nutrien, The Mosaic Company, FMC Corporation, Nufarm, ADAMA Ltd. +29 more (view full list) |
Looking for a particular Enko employee's phone or email?
Enko Questions
The Enko annual revenue was $11.6 million in 2026.
Related Companies
